555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [cách đánh đề có lãi]
Apr 28, 2025 · Xywav is used for managing: symptoms of narcolepsy in adults and certain children ages 7 years and older idiopathic hypersomnia (excessive daytime sleepiness that …
Could XYWAV be right for your adult patients with Idiopathic Hypersomnia (IH)? XYWAV is the only FDA-approved treatment for IH. 1,2 Consider XYWAV—a treatment taken each night to …
Nov 1, 2024 · Summary: At the 37th annual Psych Congress, Jazz Pharmaceuticals presented results from the phase 4 DUET trial on low-sodium Xywav, showing its effectiveness in treating …
May 5, 2025 · Xywav is used for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients with narcolepsy, and idiopathic hypersomnia (IH). Includes Xywav side …
Plain Language Summary Lower-sodium oxybate (Xywav™) is a medication for people with narcolepsy 7 years of age and older. Xywav treats excessive daytime sleepiness (EDS) and …
Apr 11, 2024 · Xywav was originally FDA-approved in 2002 to treat excessive daytime sleepiness (EDS) and cataplexy (sudden muscle weakness triggered by strong emotions) in people at …
FDA-Approved Indications Xywav is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
XYWAV oral solution, 0.5 g/mL total salts (equivalent to 0.413 g/mL of oxybate) is the only FDA‑approved treatment for cataplexy and/or excessive daytime sleepiness in narcolepsy and …
Jul 2, 2022 · For years, idiopathic hypersomnia, a neurologic sleep disorder characterized by chronic excessive daytime sleepiness (EDS), was treated with off-label wake-promoting …
Sep 23, 2024 · Xywav is a prescription drug used to treat cataplexy and excessive daytime sleepiness caused by narcolepsy. Learn about dosage, side effects, uses, and more.
Bài viết được đề xuất: